Bayer's Mycelex-3 vaginal yeast infection treatment takes "value-priced" approach.
This article was originally published in The Tan Sheet
Executive Summary
BAYER MYCELEX-3 VAGINAL YEAST INFECTION TREATMENT PROMOTIONS to include nationwide free-standing-inserts starting in April. With an anticipated total distribution of 35 mil., the FSIs for the recently launched 2% butoconazole nitrate cream will include a $3 manufacturer's coupon. Bayer is marketing the product as a value-priced version of the company's 2% butoconazole nitrate-containing Femstat-3.